CXCR2 and cancer: This study investigates the multifaceted role of CXCR2 ligands across 31 distinct cancer types, encompassing glioblastoma, melanoma, and various GI, renal, hepatic, pulmonary, gynecological, pancreatic, and prostate cancers.